Matrix Metalloproteinase-9 as a Potential Biomarker in 631 Human Implant-Induced Fibrotic Capsules: Analysis and Biomarker Study
- 2 February 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 152 (4) , 637e-645e
Abstract
Background: Capsular fibrosis (CF) often occurs around biomedical devices following implantation causing pain, discomfort, and device failure. Breast implantation remains among the most common medical procedures worldwide. Revealing specific genes that drive fibrotic deposition will help us to garner a better understanding of the pathophysiology of this disease and develop different strategies to combat it. Methods: The authors collected 631 capsules around breast implants and were able to connect clinical baseline characteristics with histopathologic findings. In addition, the authors were able to conduct the first large systematic analysis to identify differentially expressed genes in fibrotic human tissue samples, comparing the lowest form of fibrosis with the most aggravated one. Results: The authors identified 2559 differentially expressed genes on which they performed a knowledge-based network generation and pathway association study to identify putative novel biomarkers for CF. The authors were able to show changes of cellular influx during progression of CF and distinguish several genes as potential clinical biomarkers and drug targets. Among these, matrix metalloproteinase-9 was one of the most up-regulated ( P = 0.006) and is attractive because of its wide detectability. Conclusions: Matrix metalloproteinase-9 seems to be a potential biomarker to detect capsular fibrosis. It is a measurable indicator that can easily be detected in blood, sputum, and urine. For the diagnosis of fibrosis, this biomarker might be exceedingly beneficial to developing novel screening methods and prophylaxes. Clinical Relevance Statement: Discovering biomarkers at the earliest and mildest stages for the diagnosis of fibrosis is clinically important. These results bring new hope for biomarker-based diagnosis for capsular fibrosis. CLINICAL QUESTION/LEVEL OF EVIDENCE: Diagnostic, V.Keywords
This publication has 42 references indexed in Scilit:
- Bacterial biofilms and capsular contracture in patients with breast implantsBritish Journal of Surgery, 2013
- Capsular Contracture with Breast Implants in the Cosmetic Patient: Saline versus Silicone–A Systematic Review of the LiteraturePlastic and Reconstructive Surgery, 2010
- Matrix Metalloproteinase–induced Fibrosis and Malignancy in Breast and LungProceedings of the American Thoracic Society, 2008
- Bacterial Colonization Is of Major Relevance for High-Grade Capsular Contracture After Augmentation MammaplastyAnnals of Plastic Surgery, 2007
- Results of subglandular versus subpectoral augmentation over time: One surgeon's observationsAesthetic Surgery Journal, 2006
- Surgical Intervention and Capsular Contracture After Breast AugmentationAnnals of Plastic Surgery, 2005
- In vitro interaction between silicone gel and human monocyte‐macrophagesJournal of Biomedical Materials Research Part A, 2004
- Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosisClinical Science, 2003
- The Fate of Breast ImplantsPlastic and Reconstructive Surgery, 1995
- Studies on the Endogenous Flora of the Human BreastAnnals of Plastic Surgery, 1988